News Home

Do Analysts Expect Fulgent Genetics Inc (FLGT) Stock to Rise After It Is Lower By -39.56% in a Month?

Tuesday, January 25, 2022 01:45 PM | InvestorsObserver Analysts
Do Analysts Expect Fulgent Genetics Inc (FLGT) Stock to Rise After It Is Lower By -39.56% in a Month?

InvestorsObserver is giving Fulgent Genetics Inc (FLGT) an Analyst Rating Rank of 74, meaning FLGT is ranked higher by analysts than 74% of stocks. The average price target for FLGT is $141 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating FLGT a Strong Buy today. Find out what this means to you and get the rest of the rankings on FLGT!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Fulgent Genetics Inc Stock Today?

Fulgent Genetics Inc (FLGT) stock is up 2.67% while the S&P 500 has fallen -1.26% as of 1:44 PM on Tuesday, Jan 25. FLGT has risen $1.62 from the previous closing price of $60.72 on volume of 388,517 shares. Over the past year the S&P 500 has risen 12.95% while FLGT has fallen -10.94%. FLGT earned $19.24 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.24. Click Here to get the full Stock Report for Fulgent Genetics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App